[1] ROHDE U, HEDBÄCK N, GLUUD L L, et al. Effect of the Endo Barrier Gastrointestinal Liner on obesity and type 2 diabetes:Systematic review and meta-analysis[J]. Diabetes Obesity & Metabolism, 2016, 18(3):300-305.
[2] PEREIRA M A. Diet beverages and the risk of obesity, diabetes, and cardiovascular disease:A review of the evidence[J]. Nutrition Reviews, 2013, 71(7):433-440.
[3] STERRY W, STROBER B E, MENTER A. Obesity in psoriasis:The metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review[J]. British Journal Dermatology, 2007, 157(4):649-655.
[4] COMMODORE-MENSAH Y, SAMUEL L J, DENNISON-HIMMELFARB C R, et al. Hypertension and overweight/obesity in Ghanaians and Nigerians living in West Africa and industrialized countries:A systematic review[J]. Journal of Hypertension, 2014, 32(3):464-472.
[5] DESPRÉS J P, LEMIEUX I. Abdominal obesity and metabolic syndrome[J].Nature, 2006, 444(7121):881-887.
[6] KOPELMAN P G. Obesity as a medical problem[J]. Nature, 2000, 404(6778):635-643.
[7] ZHANG Z, LAM T N, ZUO Z. Radix puerariae:An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use[J]. Journal of Clinical Pharmacology, 2013, 53(8):787-811.
[8] JUNG H W, KANG A N, KANG S Y, et al. The root extract of Pueraria lobata and its main compound, puerarin, prevent obesity by increasing the energy metabolism in skeletal muscle[J]. Nutrients, 2017, 9(1):E33.
[9] ZHENG G, LIN L, ZHONG S, et al. Effects of puerarin on lipid accumulation and metabolism in high-fat diet-fed mice[J]. PLoS One, 2015, 10(3):e0122925.
[10] RAMIREZ J L, MUNOZLEDO F C, HARCUCH W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O[J]. Histochemistry,1992, 97(6):493-497.
[11] GAOLI Z, XINYUE Z, JINGWEI Z, et al. Estrogenic activity of puerarin and pueraria total isoflavones[J]. Journal of the Chinese Medicine Association, 2002, 25(8):566-568.
[12] ROSEN E D. The transcriptional basis of adipocyte development[J]. Prostaglandins Leukot Essent Fatty Acids, 2005, 73(1):31-34.
[13] SOUKAS A, SOCCI N D, SAATKAMP B D, et al. Distinct transcriptional profiles of adipogenesis in vivo and in vitro[J]. Journal of Biological Chemistry, 2001, 276(36):34167-34174.
[14] NTAMBI J M, YOUNG-CHEUL K. Adipocyte differentiation and gene expression[J]. Journal of Nutrition, 2000, 130(12):3122S-3126S.
[15] TONG Q, HOTAMISLIGIL G S. Molecular mechanisms of adipocyte differentiation[J]. Reviews in Endocrine & Metablic Disorders, 2001, 2(4):349-355.
[16] PRASAIN J K, PENG N, RAJBHANDARI R, et al. The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice[J]. Phytomedicine, 2012, 20(1):17-23.
[17] LEE O H, SEO D H, PARK C S, et al. Puerarin enhances adipocyte differentiation, adiponectin expression, and antioxidant response in 3T3-L1 cells[J]. BioFactors, 2010, 36(6):459-467.
[18] XU M E, XIAO S Z, SUN Y H, et al. The study of anti-metabolic syndrome effect of puerarin in vitro[J]. Life Sciences, 2005, 77(25):3183-3196.
[19] 王小康, 刘清霞, 叶开和, 等. 3'-羟基葛根素对脂肪细胞3T3-L1胰岛素抵抗的影响及其机制研究[J]. 中草药, 2014, 45(16):2352-2357. WANG X K, LIU Q X, YE K H, et al. Effects of 3'-hydroxy puerarin on improving insulin resistance in 3T3-L1 adipocytes and their mechanisms[J]. Chinese Traditional and Herbal Drugs, 2014, 45(16):2352-2357.(in Chinese)
[20] WANG N, WANG X, CHENG W, et al. Puerarin promotes osteogenesis and inhibits adipogenesis in vitro[J]. Chinese Medicine, 2013, 8(1):8-17.
[21] FRANKE T F,KAPLAN D R,CANTLEY L C. PI3K:Downstream AKTion blocks apoptosis[J]. Cell, 1997, 88(4):435-437.
[22] BURGERING B M, COFFER P J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction[J]. Nature, 1995, 376(6541):599-602.
[23] HAJDUCH E, LITHERLAND G J, Hundal H S. Protein kinase B (PKB/Akt)——A key regulator of glucose transport[J]. FEBS Letters, 2001, 492(3):199-203.
[24] CROSS D A, ALESSI D R, COHEN P, et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B[J]. Nature, 1995, 378(6559):785-789.
[25] ALESSI D R, ANDJELKOVIC M, CAUDWELL B, et al. Mechanism of activation of protein kinase B by insulin and IGF-1[J]. EMBO Journal, 1996, 15(23):6541-6551.
[27] SARBASSOV D D, GUERTIN D A, ALI S M, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex[J]. Science, 2005, 307(5712):1098-1101.
[27] JACINTO E, FACCHINETTI V, LIU D, et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity[J]. Cell, 2006, 127(1):125-137.
[28] ZHANG H H, HUANG J, DVVEL K, et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway[J]. PLoS One, 2009, 4(7):e6189.
[29] PENG X D, XU P Z, CHEN M L, et al. Dwarfism,impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2[J]. Genes & Development, 2003, 17(11):1352-1365.
[30] KIM S P, HA J M, YUN S J, et al. Transcriptional activation of peroxisome proliferator-activated receptor-gamma requires activation of both protein kinase A and Akt during adipocyte differentiation[J]. Biochemical Biophysical Research Communication, 2010, 399(1):55-59.
[31] SMITH P J, WISE L S, BERKOWITZ R, et al. Insulin-like growth factor-Ⅰ is an essential regulator of the differentiation of 3T3-L1 adipocytes[J]. Journal of Biological Chemistry, 1988, 263(19):9402-9408.
[32] CORNELIUS P, MACDOUGALD O A,LANE M D. Regulation of adipocyte development[J]. Annual Review of Nutrition, 1994, 14:99-129.
[33] KOHN A D, SUMMERS S A, BIRNBAUM M J, et al. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation[J].Journal of Biological Chemistry, 1996, 271(49):31372-31378.
[34] WANG J, HU X, AI W, et al. Phytol increases adipocyte number and glucose tolerance through activation of PI3K/Akt signaling pathway in mice fed high-fat and high-fructose diet[J]. Biochemical and Biophysical Research Communications, 2017, 489(4):432-438.
[35] PARK H J, YUN J, JANG S H, et al. Coprinus comatus cap inhibits adipocyte differentiation via regulation of PPARγ and Akt signaling pathway[J]. PLoS One, 2014, 9(9):e105809.
[36] CHOI K H, LEE H A, PARK M H, et al. Cyanidin-3-rutinoside increases glucose uptake by activating the PI3K/Akt pathway in 3T3-L1 adipocytes[J]. Environmental Toxicology and Pharmacology, 2017, 54:1-6.
[37] UTO-KONDO H, OHMORI R, KIYOSE C, et al. Tocotrienol suppresses adipocyte differentiation and Akt phosphorylation in 3T3-L1 preadi-pocytes[J]. Journal of Nutrition, 2009,139(1):51-57.
[38] 蒲蕾. RBP4干扰调控猪脂肪细胞PI3K/Akt信号[D]. 杨凌:西北农林科技大学,2013. PU L. Effects of retinol binding protein 4 knockdown on the PI3K/Akt signal pathway in porcine adipocytes[D]. Yangling:Northwest A & F University,2013.(in Chinese) |